Jeffrey B. Landau

Insider Reports History

Entity
Individual
Location
C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco, CA
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Jeffrey B Landau
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey B. Landau:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 119K $146K $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 4.5K $5.53K $1.23 Aug 20, 2024 Fidelity Traditional IRA
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 3.18K $3.91K $1.23 Aug 20, 2024 Schwab ROTH IRA
CytomX Therapeutics, Inc. Chief Business Officer Performance Stock Units (PSUs) 0 $0 $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 140K Jan 18, 2024 Direct

Insider Reports Filed by Jeffrey B. Landau

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTMX CytomX Therapeutics, Inc. Aug 20, 2024 3 -$5.14K 4 Aug 22, 2024 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Mar 19, 2024 1 -$13.7K 4 Mar 21, 2024 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Jan 18, 2024 3 $0 4 Jan 19, 2024 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Dec 20, 2023 1 -$5.63K 4 Dec 22, 2023 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Dec 17, 2023 2 $0 4 Dec 19, 2023 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Sep 20, 2023 2 -$5.36K 4 Sep 22, 2023 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Mar 16, 2023 1 -$2.92K 4 Mar 20, 2023 Chief Financial Officer
CTMX CytomX Therapeutics, Inc. Feb 2, 2023 3 $0 4 Feb 6, 2023 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Aug 10, 2022 2 $0 4 Aug 12, 2022 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Jul 19, 2022 2 -$5.98K 4 Jul 21, 2022 Chief Business Officer
CTMX CytomX Therapeutics, Inc. Mar 23, 2022 0 $0 3 Mar 28, 2022 Chief Business Officer